11 Einträge gefunden

1. Investigating the temporal course, relevance and risk factors of fatigue over 5 years: a prospective study among patients receiving allogeneic HSCT

   1. Esser, Peter
   2. Kuba, Katharina
   3. Mehnert, A
   4. Schwinn, A
   5. Schirmer, L
   6. Schulz-Kindermann, F
   7. Kruse, Margitta

   2017 - Forschungsinformationssystem des UKE
2. Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants.

   1. Lioznov, Michael
   2. Freiberger, P
   3. Kröger, N
   4. Zander, A R
   5. Fehse, B

   2005 - Forschungsinformationssystem des UKE
3. Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myeloma.

   1. Ayuketang Ayuk, Francis
   2. Shimoni, A
   3. Nagler, A
   4. Schwerdtfeger, R
   5. Kiehl, M
   6. Sayer, H G
   7. Zabelina, Tatjana

   2004 - Forschungsinformationssystem des UKE
4. ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML).

   1. Zander, A R
   2. Kröger, N
   3. Schleuning, M
   4. Finke, J
   5. Zabelina, Tatjana
   6. Beelen, D
   7. Schwerdtfeger, R

   2003 - Forschungsinformationssystem des UKE
5. Non-overt disseminated intravascular coagulation in patients during treatment with antithymocyte globulin for unrelated allogeneic hematopoietic stem cell transplantation.

   1. Weber, M
   2. Kröger, N
   3. Langer, F
   4. Hansen, A
   5. Zabelina, Tatjana
   6. Eifrig, B
   7. Hossfeld, D K

   2003 - Forschungsinformationssystem des UKE
6. Correlation of time to platelet engraftment with amount of transplanted CD34+CD41+ cells after allogeneic bone marrow transplantation.

   1. Begemann, Philipp
   2. Hassan, H T
   3. Kröger, N
   4. Krüger, W
   5. Kabisch, H
   6. Zander, A R

   2002 - Forschungsinformationssystem des UKE
7. [Unrelated donor stem cell transplantation in children: low toxicity using a GvHD-prophylaxis regimen with CSA, MTX, metronidazole,iv-immunoglobulin and ATG]

   1. Graf Finckenstein, F
   2. Zabelina, Tatjana
   3. Dürken, M
   4. Dahlke, J
   5. Kröger, N
   6. Krüger, W
   7. Janka-Schaub, Gritta

   2002 - Forschungsinformationssystem des UKE
8. Disseminated breast cancer cells prior to and after high-dose therapy.

   1. Krüger, W H
   2. Kröger, N
   3. Tögel, F
   4. Renges, H
   5. Badbaran, A
   6. Hornung, R
   7. Jung, Roman

   2001 - Forschungsinformationssystem des UKE
9. Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients.

   1. Kröger, N
   2. Zabelina, Tatjana
   3. Krüger, W
   4. Renges, H
   5. Stute, N
   6. Kabisch, H
   7. Jaburg, N

   2001 - Forschungsinformationssystem des UKE
10. Interference of cytokeratin-20 and mammaglobin-reverse-transcriptase polymerase chain assays designed for the detection of disseminated cancer cells.

    1. Krüger, W H
    2. Jung, Roman
    3. Detlefsen, B
    4. Mumme, S
    5. Badbaran, A
    6. Brandner, Johanna
    7. Renges, H

    2001 - Forschungsinformationssystem des UKE
11. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.

    1. Kröger, N
    2. Schetelig, J
    3. Zabelina, Tatjana
    4. Krüger, W
    5. Renges, H
    6. Stute, N
    7. Schrum, Johanna

    2001 - Forschungsinformationssystem des UKE